Bruker Corporation (BRKR)
USD 37.66
(-8.48%)
USD 37.66
(-8.48%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 599 Million USD | 8.5% |
| 2022 | 545.3 Million USD | 6.52% |
| 2021 | 497.1 Million USD | 46.13% |
| 2020 | 320.7 Million USD | -7.68% |
| 2019 | 380 Million USD | 10.44% |
| 2018 | 340.1 Million USD | 16.26% |
| 2017 | 299.5 Million USD | 15.93% |
| 2016 | 262.1 Million USD | 12.55% |
| 2015 | 235.9 Million USD | 9.22% |
| 2014 | 215.6 Million USD | -12.1% |
| 2013 | 239.1 Million USD | 9.47% |
| 2012 | 211.7 Million USD | 37.14% |
| 2011 | 205.7 Million USD | -1.8% |
| 2010 | 155.7 Million USD | -59.37% |
| 2009 | 166.3 Million USD | 143.42% |
| 2008 | 134.8 Million USD | 124.37% |
| 2007 | 63.07 Million USD | 40.87% |
| 2006 | 49.86 Million USD | 168.45% |
| 2005 | 19.24 Million USD | 121.86% |
| 2004 | 8.67 Million USD | -43.68% |
| 2003 | 697 Thousand USD | -36.37% |
| 2002 | 17.47 Million USD | 169.73% |
| 2001 | 10.29 Million USD | 76.41% |
| 2000 | 4.87 Million USD | -28.07% |
| 1999 | 6.66 Million USD | 4492.81% |
| 1998 | -161 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 113.3 Million USD | -34.61% |
| 2024 Q3 | -76.9 Million USD | -5.4% |
| 2024 Q2 | 119.3 Million USD | 10.34% |
| 2023 Q2 | 117.5 Million USD | -23.25% |
| 2023 FY | - USD | 8.5% |
| 2023 Q1 | 153.1 Million USD | -5.14% |
| 2023 Q4 | 144.9 Million USD | -9.72% |
| 2023 Q3 | 160.5 Million USD | 36.6% |
| 2022 FY | - USD | 6.52% |
| 2022 Q1 | 125.7 Million USD | -17.95% |
| 2022 Q2 | 106.4 Million USD | -15.35% |
| 2022 Q3 | 155.3 Million USD | 45.96% |
| 2022 Q4 | 161.4 Million USD | 3.93% |
| 2021 FY | - USD | 46.13% |
| 2021 Q3 | 137.5 Million USD | 23.21% |
| 2021 Q2 | 111.6 Million USD | -2.45% |
| 2021 Q1 | 114.4 Million USD | -22.28% |
| 2021 Q4 | 153.2 Million USD | 11.42% |
| 2020 Q3 | 105.9 Million USD | 79.8% |
| 2020 FY | - USD | -7.68% |
| 2020 Q4 | 147.2 Million USD | 39.0% |
| 2020 Q2 | 58.9 Million USD | 41.59% |
| 2020 Q1 | 41.6 Million USD | -69.77% |
| 2019 FY | - USD | 10.44% |
| 2019 Q4 | 137.6 Million USD | 35.7% |
| 2019 Q1 | 67.2 Million USD | -47.21% |
| 2019 Q2 | 76.8 Million USD | 14.29% |
| 2019 Q3 | 101.4 Million USD | 32.03% |
| 2018 Q1 | 61.7 Million USD | -46.49% |
| 2018 Q2 | 67.6 Million USD | 9.56% |
| 2018 FY | - USD | 16.26% |
| 2018 Q4 | 127.3 Million USD | 41.13% |
| 2018 Q3 | 90.2 Million USD | 33.43% |
| 2017 Q1 | 55.8 Million USD | -41.88% |
| 2017 FY | - USD | 15.93% |
| 2017 Q3 | 71.3 Million USD | 27.55% |
| 2017 Q4 | 115.3 Million USD | 61.71% |
| 2017 Q2 | 55.9 Million USD | 0.18% |
| 2016 FY | - USD | 12.55% |
| 2016 Q4 | 96 Million USD | 49.53% |
| 2016 Q3 | 64.2 Million USD | 39.87% |
| 2016 Q2 | 45.9 Million USD | -10.35% |
| 2016 Q1 | 51.2 Million USD | -40.05% |
| 2015 Q3 | 50.4 Million USD | 8.15% |
| 2015 FY | - USD | 9.22% |
| 2015 Q4 | 85.4 Million USD | 69.44% |
| 2015 Q1 | 41.9 Million USD | -42.13% |
| 2015 Q2 | 46.6 Million USD | 11.22% |
| 2014 Q1 | 39.4 Million USD | -53.32% |
| 2014 Q3 | 34.8 Million USD | -37.63% |
| 2014 Q4 | 72.4 Million USD | 108.05% |
| 2014 FY | - USD | -12.1% |
| 2014 Q2 | 55.8 Million USD | 41.62% |
| 2013 FY | - USD | 9.47% |
| 2013 Q4 | 84.4 Million USD | 47.55% |
| 2013 Q3 | 57.2 Million USD | -9.21% |
| 2013 Q2 | 63 Million USD | 88.06% |
| 2013 Q1 | 33.5 Million USD | -63.27% |
| 2012 FY | - USD | 37.14% |
| 2012 Q1 | 34.4 Million USD | -55.56% |
| 2012 Q2 | 22.1 Million USD | -35.76% |
| 2012 Q3 | 60.3 Million USD | 172.85% |
| 2012 Q4 | 91.2 Million USD | 51.24% |
| 2011 FY | - USD | -1.8% |
| 2011 Q1 | 29.6 Million USD | -51.55% |
| 2011 Q3 | 38.3 Million USD | -2.79% |
| 2011 Q2 | 39.4 Million USD | 33.11% |
| 2011 Q4 | 77.4 Million USD | 102.09% |
| 2010 Q3 | 41.4 Million USD | -3.27% |
| 2010 Q2 | 42.8 Million USD | 51.77% |
| 2010 FY | - USD | -59.37% |
| 2010 Q4 | 61.1 Million USD | 47.58% |
| 2010 Q1 | 28.2 Million USD | -66.9% |
| 2009 Q1 | 21.5 Million USD | -68.93% |
| 2009 FY | - USD | 143.42% |
| 2009 Q4 | 85.2 Million USD | -6.37% |
| 2009 Q3 | 91 Million USD | 331.28% |
| 2009 Q2 | 21.1 Million USD | -1.86% |
| 2008 FY | - USD | 124.37% |
| 2008 Q4 | 69.2 Million USD | 357.28% |
| 2008 Q3 | 15.13 Million USD | -41.78% |
| 2008 Q2 | 25.99 Million USD | -34.21% |
| 2008 Q1 | 39.5 Million USD | 18.04% |
| 2007 Q1 | 8.14 Million USD | -46.2% |
| 2007 Q2 | 6.61 Million USD | -18.71% |
| 2007 FY | - USD | 40.87% |
| 2007 Q3 | 11.92 Million USD | 80.21% |
| 2007 Q4 | 33.46 Million USD | 180.63% |
| 2006 Q2 | 3.63 Million USD | -8.06% |
| 2006 Q1 | 3.95 Million USD | -7.11% |
| 2006 FY | - USD | 168.45% |
| 2006 Q3 | 8.92 Million USD | 145.44% |
| 2006 Q4 | 15.13 Million USD | 69.48% |
| 2005 FY | - USD | 121.86% |
| 2005 Q2 | 911 Thousand USD | -69.37% |
| 2005 Q1 | 2.97 Million USD | 53.46% |
| 2005 Q3 | 2.92 Million USD | 221.41% |
| 2005 Q4 | 4.26 Million USD | 45.49% |
| 2004 Q1 | 1.69 Million USD | 537.11% |
| 2004 Q3 | 255 Thousand USD | 104.83% |
| 2004 Q4 | 1.93 Million USD | 660.0% |
| 2004 Q2 | -5.27 Million USD | -411.14% |
| 2004 FY | - USD | -43.68% |
| 2003 Q2 | -3 Million USD | -93.3% |
| 2003 Q1 | 2.12 Million USD | -51.64% |
| 2003 Q4 | -388 Thousand USD | 69.03% |
| 2003 Q3 | -5.54 Million USD | -661.88% |
| 2003 FY | - USD | -36.37% |
| 2002 Q1 | 1.34 Million USD | 25.28% |
| 2002 FY | - USD | 169.73% |
| 2002 Q4 | 1.3 Million USD | 202.19% |
| 2002 Q3 | 1.31 Million USD | -15.47% |
| 2002 Q2 | 1.98 Million USD | 99.93% |
| 2001 Q1 | 501 Thousand USD | 158.94% |
| 2001 FY | - USD | 76.41% |
| 2001 Q4 | 1.05 Million USD | 74.68% |
| 2001 Q3 | 616 Thousand USD | 7.13% |
| 2001 Q2 | 575 Thousand USD | 14.77% |
| 2000 Q2 | 448 Thousand USD | -66.33% |
| 2000 Q1 | 1.58 Million USD | 0.0% |
| 2000 Q4 | -850 Thousand USD | -2261.11% |
| 2000 Q3 | -36 Thousand USD | -105.59% |
| 2000 FY | - USD | -28.07% |
| 1999 FY | - USD | 4492.81% |
| 1998 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 4541.314% |
| Cerus Corporation | -26.53 Million USD | 2357.311% |
| OrthoPediatrics Corp. | -8.38 Million USD | 7247.118% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 5807.757% |
| Talis Biomedical Corporation | -66.04 Million USD | 1006.957% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 3692.204% |
| Inogen, Inc. | -45.67 Million USD | 1411.325% |
| Spectral AI, Inc. | -12.26 Million USD | 4985.011% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 1355.95% |
| CVRx, Inc. | -38.73 Million USD | 1646.565% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 17078.458% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 5047.551% |
| Orthofix Medical Inc. | -86.98 Million USD | 788.624% |
| Venus Concept Inc. | -26.11 Million USD | 2393.877% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 1303.512% |
| Bioventus Inc. | -23.07 Million USD | 2696.446% |
| BrainsWay Ltd. | -2.31 Million USD | 26019.515% |
| Envoy Medical, Inc. | -18.23 Million USD | 3384.351% |
| electroCore, Inc. | -17.76 Million USD | 3472.748% |
| IceCure Medical Ltd | -15.25 Million USD | 4027.096% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 1303.996% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 3653.695% |
| MaxCyte, Inc. | -44.12 Million USD | 1457.415% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 5195.277% |
| Nexalin Technology, Inc. | -5.69 Million USD | 10623.464% |
| PAVmed Inc | -75.74 Million USD | 890.843% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 1214.253% |
| RxSight, Inc. | -41.03 Million USD | 1559.658% |
| Sight Sciences, Inc. | -49.41 Million USD | 1312.183% |
| SI-BONE, Inc. | -34.44 Million USD | 1838.954% |
| TELA Bio, Inc. | -40.63 Million USD | 1574.171% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 1127.48% |
| Treace Medical Concepts, Inc. | -39 Million USD | 1635.582% |
| LivaNova PLC | 39.01 Million USD | -1435.268% |
| 908 Devices Inc. | -34.02 Million USD | 1860.47% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 641.63% |
| Nemaura Medical Inc. | -7.28 Million USD | 8320.054% |
| NeuroPace, Inc. | -22.83 Million USD | 2723.281% |
| LENSAR, Inc. | -8.71 Million USD | 6973.996% |
| Apyx Medical Corporation | -18.11 Million USD | 3407.2% |
| Cutera, Inc. | -136.56 Million USD | 538.632% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 17821.893% |
| BioSig Technologies, Inc. | -28.15 Million USD | 2227.811% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -23707.631% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 2953.876% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | -56.165% |
| Axonics, Inc. | 7.77 Million USD | -7604.18% |
| Outset Medical, Inc. | -153.78 Million USD | 489.495% |
| IRIDEX Corporation | -7.44 Million USD | 8142.427% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 710.633% |
| IRadimed Corporation | 20.8 Million USD | -2779.719% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 7529.919% |
| INVO Bioscience, Inc. | -6.88 Million USD | 8806.366% |
| Telesis Bio, Inc. | -40.49 Million USD | 1579.268% |
| Viemed Healthcare, Inc. | 36.67 Million USD | -1533.176% |
| Varex Imaging Corporation | 67.2 Million USD | -791.369% |
| Quipt Home Medical Corp. | 44.07 Million USD | -1259.17% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 5610.58% |
| Pulmonx Corporation | -55.09 Million USD | 1187.272% |
| Dynatronics Corporation | -976 Thousand USD | 61472.448% |
| Modular Medical, Inc. | -17.1 Million USD | 3602.31% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 4235.312% |
| Semler Scientific, Inc. | 23.58 Million USD | -2439.319% |
| InMode Ltd. | 196.28 Million USD | -205.172% |
| Cytosorbents Corporation | -28.81 Million USD | 2179.08% |
| DexCom, Inc. | 916.7 Million USD | 34.657% |
| Align Technology, Inc. | 799.03 Million USD | 25.035% |
| Viveve Medical, Inc. | -20.61 Million USD | 3005.369% |
| ZimVie Inc. | 91.07 Million USD | -557.714% |
| Movano Inc. | -29.12 Million USD | 2156.652% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 13688.932% |
| Nexalin Technology, Inc. | -5.69 Million USD | 10623.464% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 17078.458% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 407.721% |
| Profound Medical Corp. | -27.12 Million USD | 2308.421% |
| Insulet Corporation | 323.6 Million USD | -85.105% |
| enVVeno Medical Corporation | -25.01 Million USD | 2494.276% |
| Surmodics, Inc. | 1.18 Million USD | -50320.875% |
| iCAD, Inc. | -6.56 Million USD | 9224.143% |
| Nuwellis, Inc. | -16.35 Million USD | 3762.265% |
| Biotricity, Inc. | -8.82 Million USD | 6885.022% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 718.406% |
| Aethlon Medical, Inc. | -11.84 Million USD | 5155.229% |
| InspireMD, Inc. | -20.91 Million USD | 2964.521% |
| PAVmed Inc. | -75.74 Million USD | 890.843% |
| BIOLASE, Inc. | -15.13 Million USD | 4056.668% |
| Beyond Air, Inc. | -59.03 Million USD | 1114.721% |
| FONAR Corporation | 28.25 Million USD | -2020.237% |
| AxoGen, Inc. | -13.32 Million USD | 4594.298% |
| Vivani Medical, Inc. | -26.6 Million USD | 2351.203% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | -2340.813% |
| Inari Medical, Inc. | 7.11 Million USD | -8321.201% |
| UFP Technologies, Inc. | 72.74 Million USD | -723.447% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 17791.608% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 9830.352% |
| Tenon Medical, Inc. | -15.52 Million USD | 3957.548% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 4023.752% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 1544.217% |
| AdaptHealth Corp. | -171.09 Million USD | 450.106% |
| Sintx Technologies, Inc. | -6.6 Million USD | 9175.758% |
| NanoVibronix, Inc. | -3.43 Million USD | 17538.137% |
| Quanterix Corporation | -38.08 Million USD | 1672.674% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 5610.58% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -1996566.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 316.026% |
| TransMedics Group, Inc. | -7.6 Million USD | 7978.469% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 2852.125% |
| NeuroMetrix, Inc. | -7.09 Million USD | 8541.603% |
| Hyperfine, Inc. | -47.06 Million USD | 1372.816% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 1127.321% |
| Biomerica, Inc. | -5.99 Million USD | 10094.994% |
| Bone Biologics Corporation | 479.57 Thousand USD | -124803.039% |
| AVITA Medical, Inc. | -39.56 Million USD | 1613.859% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 6630.082% |
| Silk Road Medical, Inc | -45.08 Million USD | 1428.749% |